Section Editor: Kianoosh Keyhanian MD FRCPC
September 2, 2026
A leiomyoma is a noncancerous (benign) tumor that grows in the muscular wall of the uterus. It is made of smooth muscle cells, the same cells that make up the uterine wall, called the myometrium. In the uterus, leiomyoma and fibroid mean the same thing. Pathologists tend to write leiomyoma, and everyone else tends to say fibroid.
Leiomyomas are the most common tumor of the female reproductive tract. By the age of 50, roughly 70 out of every 100 white women and around 80 out of every 100 Black women have at least one. Many never know it. Most people who have them have more than one.
A leiomyoma is not cancer, and it does not spread to other parts of the body. This article will help you understand what this diagnosis means on your pathology report, what each term means, and why it matters for your care.
Each leiomyoma begins when a single smooth muscle cell in the wall of the uterus acquires a genetic change and starts dividing more than it should. All the cells in one fibroid descend from that original cell, which is why a person can have several fibroids that behave quite differently from one another.
The genetic changes involved are usually acquired during life rather than inherited. A gene called MED12 is altered in most fibroids, and changes affecting a gene called HMGA2 account for many of the rest. Neither is tested for in routine practice, and neither will appear on your pathology report.
Growth depends on estrogen and progesterone, which is why fibroids appear during the reproductive years, may enlarge during pregnancy, and usually shrink after menopause. Several factors make them more likely.
Having given birth several times is associated with a lower likelihood of developing fibroids.
Most fibroids cause no symptoms at all, and many are found by chance during an examination, an imaging test, or surgery performed for another reason. When symptoms do occur, they depend more on where the fibroid sits than on its size.
Your report and your imaging results will describe where each fibroid sits in the wall of the uterus. This is the single most useful piece of information for explaining your symptoms, because location matters more than size.
Fibroids are usually identified on an ultrasound, and MRI is used when more detail is needed about size, number, and position. A saline infusion sonohysterogram, in which fluid is placed in the uterus during a scan, shows submucosal fibroids particularly well.
A pathologist makes a definite diagnosis by examining the tissue under a microscope. The tissue reaches the laboratory after a myomectomy, in which the fibroids alone are removed, or after a hysterectomy. In many cases, the uterus was removed for another reason, and the fibroid was an incidental finding.
Imaging cannot tell the different types of fibroid apart, and it cannot reliably separate a fibroid from a rare cancer of the same tissue. That distinction is made under the microscope.
A leiomyoma is a benign smooth muscle tumor of the uterus, well defined and separate from the surrounding wall. To the naked eye, it is firm and white, with a whorled cut surface, and it bulges when cut. Under the microscope, the pathologist looks for the following features.
As fibroids grow and age, parts of the tumor break down. Pathologists call this degenerative change, and it is very common, particularly in larger fibroids that have been present for a long time. Your report may describe the tissue as hyalinized, cystic, myxoid, or calcified, all of which are forms of this breakdown.
Some fibroids grow so large that blood cannot reach the entire tumor. Cells that lose their blood supply die, a process called necrosis. When the pattern resembles an infarct, meaning tissue killed by loss of blood supply, it is called infarct-like necrosis. This is expected after treatment with hormone medication or after uterine artery embolization, a procedure that deliberately blocks blood flow to shrink a fibroid. A particular form called red degeneration can occur during pregnancy and causes sudden pain.
The word necrosis also appears in the criteria used to diagnose cancer, so seeing it in a benign report is understandably confusing. The two are not the same. Infarct-like necrosis shows a zone of healing tissue between the dead and living areas. Tumor cell necrosis, the kind that counts toward a diagnosis of cancer, has an abrupt border with no healing zone. Distinguishing between them is a routine part of the pathologist’s assessment.
Most fibroids are reported simply as leiomyoma. Some have a feature that earns a more specific name. The names below all describe benign tumors, and all are treated the same way.
One point about bizarre nuclei is worth knowing. A proportion of these tumors result from loss of a gene called fumarate hydratase. When a pathologist sees that pattern, the report may recommend testing. In some families the same gene change is inherited, and it is linked to a condition called hereditary leiomyomatosis and renal cell cancer. That condition carries a risk of kidney cancer that benefits from early detection. Most fibroids have nothing to do with it, but if your report raises fumarate hydratase or recommends genetic assessment, follow that up rather than setting it aside.
The short answer is no. A uterine leiomyosarcoma is a cancer made of the same kind of smooth muscle cells. Evidence indicates these cancers arise on their own rather than developing from an existing fibroid.
The numbers are reassuring when you put them side by side. Around 70 in every 100 women develop fibroids at some point, while leiomyosarcoma affects roughly 6 people in every million each year. Pathologists separate the two using three features together: how many cells are dividing, whether the cells look abnormal, and whether tumor cell necrosis is present. A diagnosis of cancer generally requires a combination of these rather than any one alone.
Occasionally a tumor has a mixture of features that fits neither category cleanly. That is reported as a smooth muscle tumor of uncertain malignant potential, or STUMP. It is not cancer, but its behavior is less predictable, and it is followed more closely.
Treat fibroids only when they cause problems. Many need nothing at all, and most shrink after menopause. The right approach depends on your symptoms, the size and location of the fibroids, and whether you hope to become pregnant.
Your report will describe the fibroids and the rest of the uterus. Findings commonly listed include:
🔍 Search MyPathologyReport
Type what you see on your report — for example a diagnosis or test name